Head-to-head dispatch
Embody vs Telos Rx
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Embody offers compounded semaglutide and tirzepatide via injection plus a unique compounded oral tirzepatide gum formulation.
Marked down on: The $79 flat rate relies on an auto-applied promo 'locked forever' — list price in the terms is $199/mo and reviewers allege the lock isn't honored
Desk Score
The broadest published catalog in the ranking — compounded GLP-1s plus oral and microdosed tirzepatide, PT-141, intranasal NAD+, and recovery peptides — all compounded and not FDA-approved.
Marked down on: Everything is compounded and not FDA-approved — including all peptides and the NAD+ spray
Telos Rx takes this head-to-head with the higher Desk Score, 85/100 (B) against 83/100 (B) for Embody. Embody still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Embody
83/100
B
Telos Rx
85/100
B
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Embody | Telos Rx |
|---|---|---|
| Semaglutide | $79/mo (all doses, promotional rate, compounded) | $99/mo (injectable, month-to-month; the $49 headline is only the FIRST month of the 12-month prepaid ORAL plan, which renews at $129/mo billed every 48 weeks) |
| Tirzepatide | $129/mo (all doses, promotional rate, compounded) | $139/mo injectable · $129/mo oral · $116/mo microdosed (microdosing is tirzepatide, not semaglutide) |
| Coverage | All 50 states | Not publicly listed |
| Brand-name | Compounded only | Compounded only |
| Oral option | Yes | Yes |
| Best for | Readers who want low flat-rate compounded GLP-1 pricing at every dose. | Patients who want GLP-1 care alongside peptides, NAD+, and sexual-health options on one certified platform, with a needle-free oral or microdosed route. |
| Desk Score | 83/100B | 85/100B |
The verdict
Desk pick — Telos RxTelos Rx takes this head-to-head with the higher Desk Score, 85/100 (B) against 83/100 (B) for Embody. Embody still holds its ground where its strengths line up with yours.
Choose Embody if…
Readers who want low flat-rate compounded GLP-1 pricing at every dose.
$79/mo (all doses, promotional rate, compounded) sema · $129/mo (all doses, promotional rate, compounded) tirz · All 50 states
Choose Telos Rx if…
Patients who want GLP-1 care alongside peptides, NAD+, and sexual-health options on one certified platform, with a needle-free oral or microdosed route.
$99/mo (injectable, month-to-month; the $49 headline is only the FIRST month of the 12-month prepaid ORAL plan, which renews at $129/mo billed every 48 weeks) sema · $139/mo injectable · $129/mo oral · $116/mo microdosed (microdosing is tirzepatide, not semaglutide) tirz · Not publicly listed
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Embody · Telos Rx.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Embody vs CoreAge Rx
- Telos Rx vs Vaylen
- Embody vs Strut Health
- Telos Rx vs Ondra Health
- Embody vs Invigor Medical
- Telos Rx vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.